Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Breast Cancer

Free Subscription Articles published in BMJ Retrieve available abstracts of 47 articles: HTML format

Single Articles

September 2024
1. TANNE JH
   US women must be told breast density after mammogram, says FDA.
   BMJ. 2024;386:q2045.
   PubMed    
   
   
   
2. LEE SF, Kennedy SKF, Caini S, Wong HCY, et al
   Randomised controlled trials on radiation dose fractionation in breast cancer: systematic review and meta-analysis with emphasis on side effects and cosmesis.
   BMJ. 2024;386:e079089.
   PubMed     Abstract available
   
   
   August 2024
3. BAUM M
   Breast cancer screening does not improve length or quality of life.
   BMJ. 2024;386:q1752.
   PubMed    
   
   
   
4. AUTIER P
   Breast cancer screening expansion: modelling doesn't reflect real life and should not be used to update guidance.
   BMJ. 2024;386:q1750.
   PubMed    
   
   
   July 2024
5. RIMMER A
   Navigating breastfeeding through cancer treatment.
   BMJ. 2024;386:q1284.
   PubMed    
   
   
   June 2024
6. BELL KJ, Nickel B, Pathirana T, Blennerhassett M, et al
   Breast cancer screening from age 40 in the US.
   BMJ. 2024;385:q1353.
   PubMed    
   
   
   May 2024
7. TANNE JH
   US expert panel says breast cancer screening should begin at 40.
   BMJ. 2024;385:q1020.
   PubMed    
   
   
   April 2024
8. WISE J
   Breast cancer: Inaction on inequalities has led to unequal progress, say experts.
   BMJ. 2024;385:q854.
   PubMed    
   
   
   February 2024
9. FREEMAN K, Jenkinson D, Clements K, Wallis MG, et al
   Atypia detected during breast screening and subsequent development of cancer: observational analysis of the Sloane atypia prospective cohort in England.
   BMJ. 2024;384:e077039.
   PubMed     Abstract available
   
   
   January 2024
10. MANNU GS, Wang Z, Dodwell D, Broggio J, et al
    Invasive breast cancer and breast cancer death after non-screen detected ductal carcinoma in situ from 1990 to 2018 in England: population based cohort study.
    BMJ. 2024;384:e075498.
    PubMed     Abstract available
    
    
    
11. SCHMIDT MK, Lips EH, Schmitz RS, Verschuur E, et al
    Invasive breast cancer and breast cancer death after non-screen detected ductal carcinoma in situ.
    BMJ. 2024;384:q22.
    PubMed    
    
    
    
12. SARKAR S
    How patriarchy and conservatism fuel deadly hesitancy among women with breast cancer.
    BMJ. 2024;384:p2563.
    PubMed    
    
    
    November 2023
13. WEAVER N
    We must remove access barriers to endocrine drugs for breast cancer prevention.
    BMJ. 2023;383:p2709.
    PubMed    
    
    
    
14. 
    Pyrotinib versus placebo in combination with trastuzumab and docetaxel as first line treatment in patients with HER2 positive metastatic breast cancer (PHILA): randomised, double blind, multicentre, phase 3 trial.
    BMJ. 2023;383:p2665.
    PubMed    
    
    
    
15. MAHASE E
    Anastrozole: Repurposed drug could prevent thousands of breast cancer cases.
    BMJ. 2023;383:p2608.
    PubMed    
    
    
    October 2023
16. MA F, Yan M, Li W, Ouyang Q, et al
    Pyrotinib versus placebo in combination with trastuzumab and docetaxel as first line treatment in patients with HER2 positive metastatic breast cancer (PHILA): randomised, double blind, multicentre, phase 3 trial.
    BMJ. 2023;383:e076065.
    PubMed     Abstract available
    
    
    
17. SCHMITZ RSJM, van den Belt-Dusebout AW, Clements K, Ren Y, et al
    Association of DCIS size and margin status with risk of developing breast cancer post-treatment: multinational, pooled cohort study.
    BMJ. 2023;383:e076022.
    PubMed     Abstract available
    
    
    September 2023
18. DAVIES EA, Wang YH
    Understanding inequalities in breast cancer screening uptake.
    BMJ. 2023;382:p2084.
    PubMed    
    
    
    
19. HOFVIND S, Iqbal N, Thy JE, Mangerud G, et al
    Effect of invitation letter in language of origin on screening attendance: randomised controlled trial in BreastScreen Norway.
    BMJ. 2023;382:e075465.
    PubMed     Abstract available
    
    
    
20. CATHCART-RAKE EJ, Tevaarwerk AJ, Haddad TC, D'Andre SD, et al
    Advances in the care of breast cancer survivors.
    BMJ. 2023;382:e071565.
    PubMed     Abstract available
    
    
    
21. OKE JL, Welch HG
    Breast cancer: conflating case fatality with mortality.
    BMJ. 2023;382:p2086.
    PubMed    
    
    
    August 2023
22. MAHASE E
    Breast cancer screening: Overdiagnosis increases significantly with age, researchers say.
    BMJ. 2023;382:p1823.
    PubMed    
    
    
    July 2023
23. 
    Breast cancer mortality in 500 000 women with early invasive breast cancer in England, 1993-2015: population based observational cohort study.
    BMJ. 2023;382:p1744.
    PubMed    
    
    
    June 2023
24. TAYLOR C, McGale P, Probert J, Broggio J, et al
    Breast cancer mortality in 500 000 women with early invasive breast cancer in England, 1993-2015: population based observational cohort study.
    BMJ. 2023;381:e074684.
    PubMed     Abstract available
    
    
    
25. MACKENZIE M, Stobart H, Dodwell D, Taylor C, et al
    Risk of breast cancer death after a diagnosis of early invasive breast cancer.
    BMJ. 2023;381:p1355.
    PubMed    
    
    
    
26. KIRBY AM, Holt F, Taylor CW, Haviland JS, et al
    Should patients requiring radiotherapy for breast cancer be treated with proton beam therapy?
    BMJ. 2023;381:e072896.
    PubMed    
    
    
    May 2023
27. LEON-FERRE RA, Goetz MP
    Advances in systemic therapies for triple negative breast cancer.
    BMJ. 2023;381:e071674.
    PubMed     Abstract available
    
    
    
28. TANNE JH
    Breast cancer: US recommends women start screening at 40.
    BMJ. 2023;381:1077.
    PubMed    
    
    
    
29. CLIFT AK, Dodwell D, Lord S, Petrou S, et al
    Development and internal-external validation of statistical and machine learning models for breast cancer prognostication: cohort study.
    BMJ. 2023;381:e073800.
    PubMed     Abstract available
    
    
    April 2023
30. GATHANI T, Cutress R, Horgan K, Kirwan C, et al
    Age and sex can predict cancer risk in people referred with breast symptoms.
    BMJ. 2023;381:e073269.
    PubMed    
    
    
    March 2023
31. FLEMING B, Edison P, Kenny L
    Cognitive impairment after cancer treatment: mechanisms, clinical characterization, and management.
    BMJ. 2023;380:e071726.
    PubMed     Abstract available
    
    
    February 2023
32. BERDZULI N
    Breast cancer: from awareness to access.
    BMJ. 2023;380:290.
    PubMed    
    
    
    January 2023
33. LIMB M
    Black women in England are at greater risk of late cancer diagnosis than white women.
    BMJ. 2023;380:211.
    PubMed    
    
    
    September 2022
34. BUNDRED JR, Michael S, Stuart B, Cutress RI, et al
    Margin status and survival outcomes after breast cancer conservation surgery: prospectively registered systematic review and meta-analysis.
    BMJ. 2022;378:e070346.
    PubMed     Abstract available
    
    
    
35. BUNDRED NJ, Bundred JR, Cutress RI, Dodwell D, et al
    Width of excision margins after breast conserving surgery for invasive breast cancer and distant recurrence and survival.
    BMJ. 2022;378:o2077.
    PubMed    
    
    
    July 2022
36. MENKES DB, Hoeh NR
    Doctor-patient relationship is essential to curtail overdiagnosis.
    BMJ. 2022;378:o1750.
    PubMed    
    
    
    
37. WISE J
    NICE approves two more treatment options for advanced breast cancer.
    BMJ. 2022;378:o1751.
    PubMed    
    
    
    June 2022
38. IACOBUCCI G
    NICE recommends new targeted treatment for early breast cancer.
    BMJ. 2022;377:o1491.
    PubMed    
    
    
    
39. PAPAUTSKY EL
    A full time job: a year with early-stage breast cancer.
    BMJ. 2022;377:o1421.
    PubMed    
    
    
    May 2022
40. WISE J
    NICE allows immunotherapy treatment for small group of patients with advanced triple negative breast cancer.
    BMJ. 2022;377:o1311.
    PubMed    
    
    
    
41. WISE J
    Breast cancer: NICE recommends innovative magnetic technology for locating sentinel lymph nodes.
    BMJ. 2022;377:o1226.
    PubMed    
    
    
    March 2022
42. SAUL H, Gursul D, Cassidy S, Vinogradova Y, et al
    Risk of breast cancer with HRT depends on therapy type and duration.
    BMJ. 2022;376:o485.
    PubMed     Abstract available
    
    
    
43. TANNE JH
    Breast cancer is overdiagnosed in one in six or seven cases, finds large US study.
    BMJ. 2022;376:o581.
    PubMed    
    
    
    January 2022
44. BARTHOLOMEW T, Colleoni M, Schmidt H
    Financial incentives for breast cancer screening undermine informed choice.
    BMJ. 2022;376:e065726.
    PubMed    
    
    
    December 2021
45. CONFORTI F, Pala L, Sala I, Oriecuia C, et al
    Evaluation of pathological complete response as surrogate endpoint in neoadjuvant randomised clinical trials of early stage breast cancer: systematic review and meta-analysis.
    BMJ. 2021;375:e066381.
    PubMed     Abstract available
    
    
    
46. KRZYZANOWSKA MK, Julian JA, Gu CS, Powis M, et al
    Remote, proactive, telephone based management of toxicity in outpatients during adjuvant or neoadjuvant chemotherapy for early stage breast cancer: pragmatic, cluster randomised trial.
    BMJ. 2021;375:e066588.
    PubMed     Abstract available
    
    
    November 2021
47. BRUCE J, Mazuquin B, Canaway A, Hossain A, et al
    Exercise versus usual care after non-reconstructive breast cancer surgery (UK PROSPER): multicentre randomised controlled trial and economic evaluation.
    BMJ. 2021;375:e066542.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge.